Preliminary Results Presentation for the year ended 31 March 2019
To view the presentation of the preliminary results for the year ended 31 March 2019 please click here.
A recording of the webcast can be accessed via the following link:
https://webcasting.buchanan.uk.com/broadcast/5d011332221579216107d918
ARM Cell & Gene : Meeting on the Med – 23-25 April 2019
Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation
Proactive investors ‘ReNeuron Group agrees £80mln cell therapy licensing deal for China’
H.C. Wainwright & Co. global life sciences conference
ReNeuron will be presenting at the H.C. Wainwright & Co. global life sciences conference in London on April 9th, 2019.
Details of the conference can be found on our Events page.
The ReNeuron presentation can be accessed by webcast on April 9, 2019 3:30 p.m. (BST)
Click here to register for the webcast…
ARM Cell & Gene Therapy Investor Day, NY webcast 21 March 2019
Alliance for Regenerative Medicine : Cell & Gene investor day
Olav Hellebo, ReNeuron CEO will be presenting via webcast at the Alliance for Regenerative Medicine : Cell & Gene investor day on March 21, 2019.
ReNeuron’s slot is approximately 9.10am Eastern time (approx. 1.10 pm UK time)
To listen, please follow the link to access further information
Click to access webcast…
Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’
Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’
Proactive Investors : “ReNeuron signs exosome collaboration deal with US biopharma”
